Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Developing Countries | 86 | 2024 | 2789 | 6.700 |
Why?
|
Delivery of Health Care | 78 | 2023 | 5304 | 5.630 |
Why?
|
Investments | 15 | 2023 | 143 | 4.670 |
Why?
|
Tuberculosis | 47 | 2021 | 1904 | 4.470 |
Why?
|
Financing, Organized | 19 | 2023 | 202 | 4.440 |
Why?
|
National Health Programs | 16 | 2019 | 445 | 4.030 |
Why?
|
Research Support as Topic | 13 | 2020 | 704 | 3.960 |
Why?
|
Health Policy | 40 | 2021 | 2657 | 3.700 |
Why?
|
Public Sector | 11 | 2020 | 264 | 2.800 |
Why?
|
Biomedical Research | 23 | 2023 | 3306 | 2.760 |
Why?
|
International Cooperation | 27 | 2020 | 1421 | 2.710 |
Why?
|
Financing, Government | 17 | 2021 | 468 | 2.710 |
Why?
|
Health Services Accessibility | 44 | 2023 | 5133 | 2.560 |
Why?
|
Financial Support | 12 | 2016 | 115 | 2.450 |
Why?
|
HIV Infections | 59 | 2021 | 16678 | 2.410 |
Why?
|
Malaria | 20 | 2017 | 1232 | 2.320 |
Why?
|
Research | 13 | 2018 | 1999 | 2.320 |
Why?
|
Health Services Needs and Demand | 21 | 2019 | 1411 | 2.310 |
Why?
|
Health Care Reform | 16 | 2019 | 1261 | 2.280 |
Why?
|
Government Programs | 17 | 2023 | 275 | 2.170 |
Why?
|
Health Priorities | 9 | 2021 | 379 | 2.140 |
Why?
|
Capital Financing | 6 | 2014 | 58 | 2.130 |
Why?
|
Health Expenditures | 21 | 2022 | 2346 | 2.110 |
Why?
|
Communicable Disease Control | 18 | 2022 | 854 | 2.040 |
Why?
|
Health Services | 14 | 2023 | 758 | 2.010 |
Why?
|
Poverty | 25 | 2023 | 2646 | 2.000 |
Why?
|
Private Sector | 12 | 2021 | 390 | 1.990 |
Why?
|
State Medicine | 8 | 2019 | 220 | 1.820 |
Why?
|
Health Care Costs | 17 | 2021 | 3203 | 1.750 |
Why?
|
Policy Making | 7 | 2021 | 554 | 1.740 |
Why?
|
Income | 22 | 2022 | 1904 | 1.670 |
Why?
|
Financial Management | 3 | 2023 | 160 | 1.580 |
Why?
|
Communicable Diseases | 10 | 2022 | 878 | 1.560 |
Why?
|
Primary Health Care | 16 | 2023 | 4551 | 1.560 |
Why?
|
Public Health | 20 | 2022 | 2594 | 1.560 |
Why?
|
Maternal Mortality | 9 | 2023 | 310 | 1.510 |
Why?
|
Neoplasms | 28 | 2022 | 21596 | 1.470 |
Why?
|
Goals | 13 | 2022 | 705 | 1.450 |
Why?
|
Internationality | 6 | 2021 | 1002 | 1.430 |
Why?
|
Delivery of Health Care, Integrated | 8 | 2016 | 941 | 1.400 |
Why?
|
Humans | 375 | 2024 | 742088 | 1.390 |
Why?
|
World Health Organization | 18 | 2021 | 1317 | 1.360 |
Why?
|
Cost of Illness | 13 | 2021 | 1852 | 1.300 |
Why?
|
Resource Allocation | 5 | 2017 | 341 | 1.270 |
Why?
|
Leadership | 7 | 2021 | 1357 | 1.260 |
Why?
|
Russia | 28 | 2019 | 409 | 1.250 |
Why?
|
Disabled Persons | 5 | 2023 | 1209 | 1.190 |
Why?
|
Diabetes Mellitus | 17 | 2023 | 5724 | 1.190 |
Why?
|
Cost-Benefit Analysis | 14 | 2021 | 5385 | 1.160 |
Why?
|
Capacity Building | 3 | 2018 | 248 | 1.150 |
Why?
|
Patient Acceptance of Health Care | 11 | 2020 | 3014 | 1.150 |
Why?
|
Chronic Disease | 11 | 2021 | 9144 | 1.100 |
Why?
|
Fund Raising | 3 | 2023 | 47 | 1.070 |
Why?
|
Developed Countries | 7 | 2023 | 436 | 1.050 |
Why?
|
Preventive Health Services | 3 | 2019 | 575 | 1.020 |
Why?
|
Caliciviridae Infections | 2 | 2016 | 29 | 1.020 |
Why?
|
Socioeconomic Factors | 29 | 2022 | 7770 | 1.020 |
Why?
|
Norovirus | 2 | 2016 | 35 | 1.010 |
Why?
|
Politics | 10 | 2020 | 790 | 1.000 |
Why?
|
Unemployment | 7 | 2016 | 214 | 1.000 |
Why?
|
Financing, Personal | 2 | 2018 | 308 | 1.000 |
Why?
|
Acquired Immunodeficiency Syndrome | 9 | 2013 | 2231 | 0.990 |
Why?
|
Artificial Intelligence | 5 | 2021 | 2187 | 0.960 |
Why?
|
Computer Simulation | 10 | 2023 | 6191 | 0.950 |
Why?
|
Tuberculosis, Pulmonary | 10 | 2012 | 810 | 0.930 |
Why?
|
Self-Injurious Behavior | 2 | 2019 | 462 | 0.930 |
Why?
|
Antitubercular Agents | 13 | 2012 | 1319 | 0.900 |
Why?
|
Child Mortality | 4 | 2015 | 198 | 0.890 |
Why?
|
Infectious Disease Transmission, Vertical | 5 | 2013 | 1320 | 0.870 |
Why?
|
Hospital Administrators | 2 | 2018 | 57 | 0.860 |
Why?
|
Health Personnel | 12 | 2022 | 3210 | 0.860 |
Why?
|
Reminder Systems | 4 | 2013 | 370 | 0.840 |
Why?
|
Hypertension | 11 | 2024 | 8455 | 0.840 |
Why?
|
Privatization | 2 | 2020 | 41 | 0.840 |
Why?
|
Africa South of the Sahara | 11 | 2017 | 724 | 0.830 |
Why?
|
Health Education | 6 | 2022 | 1053 | 0.820 |
Why?
|
Disease Outbreaks | 8 | 2020 | 1768 | 0.810 |
Why?
|
Conservation of Natural Resources | 4 | 2017 | 205 | 0.800 |
Why?
|
Models, Economic | 3 | 2020 | 713 | 0.780 |
Why?
|
Transients and Migrants | 2 | 2021 | 155 | 0.770 |
Why?
|
Mental Disorders | 7 | 2022 | 6587 | 0.770 |
Why?
|
Harm Reduction | 4 | 2012 | 129 | 0.770 |
Why?
|
Program Evaluation | 9 | 2019 | 2485 | 0.750 |
Why?
|
Malaysia | 7 | 2023 | 92 | 0.750 |
Why?
|
Economic Recession | 3 | 2016 | 78 | 0.740 |
Why?
|
India | 11 | 2022 | 2187 | 0.700 |
Why?
|
Diffusion of Innovation | 5 | 2015 | 725 | 0.700 |
Why?
|
Insurance, Health | 10 | 2022 | 2493 | 0.690 |
Why?
|
Health Planning | 5 | 2015 | 237 | 0.690 |
Why?
|
Drug Resistance, Bacterial | 10 | 2023 | 1032 | 0.690 |
Why?
|
Survival Analysis | 5 | 2020 | 10248 | 0.680 |
Why?
|
Anti-HIV Agents | 10 | 2012 | 4250 | 0.680 |
Why?
|
Substance Abuse, Intravenous | 5 | 2012 | 522 | 0.680 |
Why?
|
European Union | 7 | 2017 | 157 | 0.670 |
Why?
|
Maternal Welfare | 2 | 2011 | 115 | 0.670 |
Why?
|
Prenatal Care | 3 | 2016 | 1088 | 0.670 |
Why?
|
Time | 1 | 2020 | 530 | 0.670 |
Why?
|
Healthcare Disparities | 15 | 2021 | 3151 | 0.660 |
Why?
|
Child Health Services | 2 | 2017 | 667 | 0.660 |
Why?
|
Anthelmintics | 1 | 2019 | 62 | 0.660 |
Why?
|
Nervous System Diseases | 2 | 2019 | 1617 | 0.650 |
Why?
|
Helminthiasis | 1 | 2019 | 66 | 0.650 |
Why?
|
Cities | 2 | 2017 | 511 | 0.640 |
Why?
|
Cross-Sectional Studies | 45 | 2024 | 24913 | 0.630 |
Why?
|
Tuberculosis, Multidrug-Resistant | 7 | 2012 | 910 | 0.620 |
Why?
|
Prevalence | 28 | 2022 | 15194 | 0.610 |
Why?
|
Information Dissemination | 2 | 2016 | 1100 | 0.610 |
Why?
|
Anti-Infective Agents | 4 | 2023 | 971 | 0.610 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2022 | 3336 | 0.610 |
Why?
|
Epidemics | 4 | 2021 | 521 | 0.610 |
Why?
|
Mathematics | 1 | 2019 | 727 | 0.610 |
Why?
|
Directly Observed Therapy | 8 | 2012 | 137 | 0.600 |
Why?
|
Female | 118 | 2023 | 379592 | 0.600 |
Why?
|
Marburgvirus | 1 | 2016 | 20 | 0.590 |
Why?
|
Evidence-Based Practice | 1 | 2021 | 500 | 0.590 |
Why?
|
Uterine Cervical Neoplasms | 5 | 2020 | 2011 | 0.580 |
Why?
|
Quality of Health Care | 6 | 2021 | 4369 | 0.580 |
Why?
|
Turkey | 5 | 2019 | 237 | 0.570 |
Why?
|
Hepatitis | 2 | 2019 | 227 | 0.570 |
Why?
|
Program Development | 3 | 2012 | 1314 | 0.570 |
Why?
|
Hot Temperature | 1 | 2022 | 1355 | 0.560 |
Why?
|
Mortality | 9 | 2023 | 2857 | 0.550 |
Why?
|
Charities | 2 | 2013 | 31 | 0.550 |
Why?
|
Prisons | 4 | 2012 | 160 | 0.550 |
Why?
|
Fees and Charges | 1 | 2017 | 195 | 0.550 |
Why?
|
Work | 1 | 2017 | 191 | 0.540 |
Why?
|
Social Values | 1 | 2016 | 224 | 0.530 |
Why?
|
Hospitals | 7 | 2022 | 3937 | 0.530 |
Why?
|
Government | 4 | 2023 | 165 | 0.520 |
Why?
|
Drug Resistance, Multiple, Bacterial | 3 | 2018 | 563 | 0.520 |
Why?
|
Islets of Langerhans | 1 | 2022 | 1351 | 0.520 |
Why?
|
China | 10 | 2023 | 2246 | 0.520 |
Why?
|
Decision Making, Organizational | 2 | 2013 | 139 | 0.520 |
Why?
|
Academies and Institutes | 2 | 2014 | 317 | 0.520 |
Why?
|
Computer-Assisted Instruction | 1 | 2018 | 365 | 0.510 |
Why?
|
Models, Theoretical | 8 | 2021 | 3584 | 0.510 |
Why?
|
Antimalarials | 3 | 2012 | 903 | 0.510 |
Why?
|
AIDS-Related Opportunistic Infections | 4 | 2010 | 654 | 0.510 |
Why?
|
Population Surveillance | 4 | 2019 | 2616 | 0.510 |
Why?
|
Hospitalization | 5 | 2022 | 10232 | 0.500 |
Why?
|
United Nations | 6 | 2018 | 165 | 0.500 |
Why?
|
Urban Health | 1 | 2017 | 547 | 0.500 |
Why?
|
Adult | 75 | 2023 | 213712 | 0.500 |
Why?
|
Rural Population | 6 | 2022 | 2207 | 0.490 |
Why?
|
Risk Reduction Behavior | 3 | 2011 | 1123 | 0.490 |
Why?
|
Health Resources | 5 | 2019 | 911 | 0.490 |
Why?
|
Urban Population | 5 | 2022 | 2018 | 0.490 |
Why?
|
Pregnancy Complications, Infectious | 4 | 2016 | 2026 | 0.480 |
Why?
|
Diabetes Complications | 2 | 2021 | 1359 | 0.480 |
Why?
|
Hospitals, Public | 2 | 2005 | 207 | 0.480 |
Why?
|
Child | 32 | 2022 | 77478 | 0.480 |
Why?
|
Appointments and Schedules | 3 | 2013 | 414 | 0.480 |
Why?
|
Colonialism | 1 | 2014 | 25 | 0.470 |
Why?
|
Male | 90 | 2023 | 349538 | 0.470 |
Why?
|
Anti-Retroviral Agents | 3 | 2016 | 1712 | 0.470 |
Why?
|
Ebolavirus | 1 | 2016 | 263 | 0.470 |
Why?
|
Gastroenteritis | 1 | 2016 | 245 | 0.470 |
Why?
|
Drug Resistance, Microbial | 2 | 2014 | 860 | 0.470 |
Why?
|
Asia | 7 | 2013 | 607 | 0.470 |
Why?
|
Perinatal Care | 2 | 2013 | 227 | 0.460 |
Why?
|
Pneumonia, Pneumococcal | 1 | 2014 | 126 | 0.460 |
Why?
|
Health Surveys | 8 | 2022 | 4030 | 0.460 |
Why?
|
Healthy People Programs | 2 | 2012 | 53 | 0.450 |
Why?
|
Disease | 2 | 2016 | 681 | 0.450 |
Why?
|
Ghana | 4 | 2019 | 287 | 0.450 |
Why?
|
International Agencies | 2 | 2013 | 240 | 0.450 |
Why?
|
Cost Savings | 3 | 2020 | 925 | 0.450 |
Why?
|
Health Plan Implementation | 3 | 2013 | 351 | 0.450 |
Why?
|
Safety | 2 | 2017 | 1185 | 0.450 |
Why?
|
Antiretroviral Therapy, Highly Active | 4 | 2021 | 1872 | 0.450 |
Why?
|
Health Services Research | 9 | 2020 | 1834 | 0.440 |
Why?
|
Regression Analysis | 12 | 2021 | 6452 | 0.440 |
Why?
|
Estonia | 4 | 2016 | 53 | 0.440 |
Why?
|
Publications | 1 | 2015 | 195 | 0.440 |
Why?
|
Models, Statistical | 5 | 2021 | 5100 | 0.430 |
Why?
|
Health Promotion | 5 | 2014 | 2194 | 0.420 |
Why?
|
Efficiency, Organizational | 5 | 2019 | 695 | 0.420 |
Why?
|
Substance-Related Disorders | 3 | 2022 | 4250 | 0.420 |
Why?
|
Bibliometrics | 1 | 2016 | 339 | 0.420 |
Why?
|
Early Detection of Cancer | 5 | 2020 | 3070 | 0.410 |
Why?
|
Workload | 2 | 2019 | 849 | 0.410 |
Why?
|
Infant | 21 | 2021 | 35070 | 0.410 |
Why?
|
Health Care Surveys | 8 | 2020 | 2451 | 0.410 |
Why?
|
Surgical Procedures, Operative | 2 | 2020 | 1873 | 0.410 |
Why?
|
Personal Satisfaction | 1 | 2016 | 634 | 0.410 |
Why?
|
Infection Control | 3 | 2019 | 962 | 0.410 |
Why?
|
Cardiovascular Diseases | 11 | 2024 | 15108 | 0.400 |
Why?
|
Hemorrhagic Fever, Ebola | 1 | 2016 | 428 | 0.400 |
Why?
|
Interprofessional Relations | 3 | 2008 | 1008 | 0.390 |
Why?
|
Career Choice | 1 | 2017 | 743 | 0.390 |
Why?
|
Systems Integration | 2 | 2010 | 440 | 0.390 |
Why?
|
Adolescent | 33 | 2022 | 85649 | 0.390 |
Why?
|
Mexico | 5 | 2019 | 688 | 0.380 |
Why?
|
Primary Prevention | 4 | 2013 | 1166 | 0.380 |
Why?
|
Community Health Planning | 1 | 2011 | 165 | 0.380 |
Why?
|
Delayed Diagnosis | 3 | 2021 | 438 | 0.370 |
Why?
|
Europe | 7 | 2022 | 3339 | 0.370 |
Why?
|
History, 21st Century | 5 | 2017 | 1533 | 0.370 |
Why?
|
Antihypertensive Agents | 4 | 2021 | 2043 | 0.370 |
Why?
|
Budgets | 6 | 2016 | 227 | 0.370 |
Why?
|
Vaccines | 2 | 2022 | 817 | 0.370 |
Why?
|
Child, Preschool | 19 | 2021 | 40955 | 0.360 |
Why?
|
Infant, Newborn | 14 | 2020 | 25575 | 0.360 |
Why?
|
Ambulatory Care | 3 | 2020 | 2706 | 0.360 |
Why?
|
Brazil | 7 | 2021 | 1263 | 0.360 |
Why?
|
Systems Analysis | 4 | 2018 | 171 | 0.360 |
Why?
|
Middle Aged | 53 | 2023 | 213127 | 0.360 |
Why?
|
HIV Seropositivity | 4 | 2011 | 970 | 0.360 |
Why?
|
Concept Formation | 1 | 2010 | 158 | 0.350 |
Why?
|
Cardiology | 1 | 2020 | 1658 | 0.350 |
Why?
|
Health Status | 4 | 2018 | 4030 | 0.340 |
Why?
|
Pregnancy | 20 | 2023 | 29087 | 0.340 |
Why?
|
Perception | 1 | 2015 | 1188 | 0.340 |
Why?
|
Latin America | 5 | 2022 | 381 | 0.330 |
Why?
|
Perinatology | 1 | 2009 | 57 | 0.330 |
Why?
|
Health Planning Guidelines | 1 | 2009 | 163 | 0.330 |
Why?
|
Telephone | 1 | 2012 | 617 | 0.330 |
Why?
|
Medically Underserved Area | 1 | 2011 | 253 | 0.330 |
Why?
|
Neglected Diseases | 3 | 2014 | 64 | 0.330 |
Why?
|
Models, Organizational | 5 | 2021 | 574 | 0.330 |
Why?
|
Pandemics | 8 | 2023 | 8328 | 0.320 |
Why?
|
Family Practice | 4 | 2019 | 516 | 0.320 |
Why?
|
Publishing | 1 | 2015 | 833 | 0.320 |
Why?
|
Life Expectancy | 4 | 2021 | 1183 | 0.310 |
Why?
|
Medical Informatics | 1 | 2015 | 742 | 0.310 |
Why?
|
Internet | 2 | 2017 | 3062 | 0.310 |
Why?
|
Interdisciplinary Communication | 4 | 2016 | 950 | 0.310 |
Why?
|
Economic Development | 3 | 2020 | 69 | 0.310 |
Why?
|
Bacterial Infections | 3 | 2023 | 1389 | 0.310 |
Why?
|
Blood Banks | 1 | 2008 | 110 | 0.300 |
Why?
|
Social Adjustment | 1 | 2010 | 630 | 0.300 |
Why?
|
Mental Health Services | 2 | 2010 | 1643 | 0.300 |
Why?
|
Reproductive Medicine | 1 | 2009 | 108 | 0.300 |
Why?
|
Self Care | 1 | 2012 | 786 | 0.300 |
Why?
|
Aged | 38 | 2023 | 162944 | 0.300 |
Why?
|
Infant Mortality | 4 | 2016 | 754 | 0.290 |
Why?
|
Hospital Design and Construction | 1 | 2006 | 33 | 0.290 |
Why?
|
Quality Indicators, Health Care | 2 | 2020 | 1831 | 0.280 |
Why?
|
Contract Services | 1 | 2006 | 94 | 0.280 |
Why?
|
Respiratory Tract Infections | 1 | 2014 | 959 | 0.280 |
Why?
|
Review Literature as Topic | 2 | 2020 | 333 | 0.280 |
Why?
|
Insurance Coverage | 3 | 2016 | 1895 | 0.280 |
Why?
|
Randomized Controlled Trials as Topic | 9 | 2019 | 9941 | 0.280 |
Why?
|
Financing, Construction | 1 | 2005 | 1 | 0.280 |
Why?
|
Hospitals, Convalescent | 1 | 2005 | 3 | 0.270 |
Why?
|
Family | 1 | 2017 | 3144 | 0.270 |
Why?
|
Cause of Death | 5 | 2015 | 3571 | 0.270 |
Why?
|
Hepatitis B | 3 | 2020 | 695 | 0.270 |
Why?
|
Dietary Services | 1 | 2005 | 17 | 0.270 |
Why?
|
Marketing | 1 | 2008 | 208 | 0.270 |
Why?
|
Disease Management | 1 | 2016 | 2450 | 0.270 |
Why?
|
Cross Infection | 2 | 2016 | 1413 | 0.270 |
Why?
|
Drugs, Investigational | 1 | 2008 | 214 | 0.270 |
Why?
|
Young Adult | 24 | 2022 | 56350 | 0.270 |
Why?
|
Hypercholesterolemia | 2 | 2023 | 1149 | 0.260 |
Why?
|
History, 20th Century | 5 | 2018 | 2739 | 0.260 |
Why?
|
Drug Industry | 2 | 2010 | 744 | 0.260 |
Why?
|
Drug Discovery | 1 | 2013 | 1057 | 0.260 |
Why?
|
Diabetes Mellitus, Type 2 | 4 | 2023 | 11695 | 0.260 |
Why?
|
CD4 Lymphocyte Count | 4 | 2016 | 2557 | 0.260 |
Why?
|
Drug Resistance, Multiple | 1 | 2006 | 252 | 0.260 |
Why?
|
Blood Pressure | 5 | 2021 | 8541 | 0.260 |
Why?
|
Prenatal Diagnosis | 1 | 2012 | 1232 | 0.250 |
Why?
|
Antiviral Agents | 2 | 2020 | 2978 | 0.250 |
Why?
|
Health Status Indicators | 1 | 2010 | 968 | 0.250 |
Why?
|
Risk Factors | 25 | 2021 | 72145 | 0.250 |
Why?
|
Artemisinins | 3 | 2012 | 222 | 0.250 |
Why?
|
Social Welfare | 1 | 2005 | 86 | 0.250 |
Why?
|
Family Health | 3 | 2018 | 1282 | 0.250 |
Why?
|
Evidence-Based Medicine | 7 | 2019 | 3611 | 0.250 |
Why?
|
Acute Disease | 1 | 2015 | 7141 | 0.250 |
Why?
|
Botswana | 2 | 2019 | 1040 | 0.250 |
Why?
|
Students, Medical | 1 | 2017 | 1858 | 0.240 |
Why?
|
Organizational Innovation | 4 | 2013 | 559 | 0.240 |
Why?
|
Down Syndrome | 1 | 2012 | 880 | 0.240 |
Why?
|
Nutritional Support | 1 | 2005 | 168 | 0.230 |
Why?
|
Incidence | 10 | 2022 | 20928 | 0.230 |
Why?
|
Policy | 4 | 2023 | 504 | 0.230 |
Why?
|
Forecasting | 4 | 2023 | 2948 | 0.230 |
Why?
|
Pneumonia | 1 | 2015 | 2117 | 0.230 |
Why?
|
Hospital-Physician Relations | 1 | 2003 | 18 | 0.230 |
Why?
|
Organizational Case Studies | 4 | 2019 | 299 | 0.230 |
Why?
|
Patient Rights | 3 | 2013 | 125 | 0.230 |
Why?
|
Disease Transmission, Infectious | 2 | 2018 | 546 | 0.230 |
Why?
|
Organizational Objectives | 2 | 2019 | 438 | 0.220 |
Why?
|
Diagnostic Techniques and Procedures | 2 | 2023 | 213 | 0.220 |
Why?
|
Quality of Life | 3 | 2020 | 12730 | 0.220 |
Why?
|
Malaria, Falciparum | 2 | 2010 | 1071 | 0.220 |
Why?
|
Drug Costs | 1 | 2010 | 1104 | 0.220 |
Why?
|
Comorbidity | 6 | 2019 | 10372 | 0.220 |
Why?
|
Needs Assessment | 4 | 2010 | 1146 | 0.220 |
Why?
|
Hospital Administration | 1 | 2006 | 353 | 0.220 |
Why?
|
England | 5 | 2022 | 523 | 0.220 |
Why?
|
Diagnostic Imaging | 3 | 2021 | 3507 | 0.220 |
Why?
|
Cold Temperature | 2 | 2022 | 774 | 0.220 |
Why?
|
Time Factors | 12 | 2020 | 40054 | 0.220 |
Why?
|
Wounds and Injuries | 1 | 2015 | 2400 | 0.210 |
Why?
|
Quality-Adjusted Life Years | 2 | 2020 | 1679 | 0.210 |
Why?
|
Survival Rate | 5 | 2021 | 12773 | 0.210 |
Why?
|
Geography | 3 | 2021 | 669 | 0.210 |
Why?
|
Mothers | 1 | 2013 | 2163 | 0.210 |
Why?
|
Safety Management | 2 | 2019 | 782 | 0.210 |
Why?
|
Interinstitutional Relations | 3 | 2009 | 240 | 0.210 |
Why?
|
Referral and Consultation | 2 | 2012 | 3527 | 0.200 |
Why?
|
Obstetrics | 1 | 2009 | 657 | 0.200 |
Why?
|
Medically Uninsured | 2 | 2018 | 852 | 0.200 |
Why?
|
Sexual Behavior | 1 | 2011 | 2050 | 0.200 |
Why?
|
Tobacco, Smokeless | 1 | 2022 | 129 | 0.200 |
Why?
|
Fetal Blood | 1 | 2008 | 1317 | 0.200 |
Why?
|
Longevity | 1 | 2009 | 1069 | 0.200 |
Why?
|
Attitude of Health Personnel | 4 | 2017 | 3839 | 0.200 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2005 | 395 | 0.200 |
Why?
|
Health Systems Plans | 2 | 2019 | 18 | 0.200 |
Why?
|
Hepatitis C | 3 | 2020 | 1582 | 0.200 |
Why?
|
Hospital Costs | 2 | 2019 | 980 | 0.190 |
Why?
|
Research Design | 7 | 2021 | 5979 | 0.190 |
Why?
|
Health Planning Support | 1 | 2000 | 9 | 0.190 |
Why?
|
Glutamate Decarboxylase | 1 | 2022 | 246 | 0.190 |
Why?
|
Europe, Eastern | 2 | 2010 | 75 | 0.190 |
Why?
|
Chile | 1 | 2021 | 237 | 0.190 |
Why?
|
Social Class | 5 | 2022 | 1995 | 0.190 |
Why?
|
Health Facilities | 2 | 2023 | 573 | 0.190 |
Why?
|
Qatar | 1 | 2020 | 36 | 0.190 |
Why?
|
Cooperative Behavior | 4 | 2015 | 1503 | 0.190 |
Why?
|
Endemic Diseases | 2 | 2012 | 182 | 0.190 |
Why?
|
Anti-Bacterial Agents | 7 | 2023 | 7153 | 0.180 |
Why?
|
Health Behavior | 2 | 2012 | 2630 | 0.180 |
Why?
|
Sex Factors | 6 | 2021 | 10392 | 0.180 |
Why?
|
Medication Errors | 3 | 2017 | 797 | 0.180 |
Why?
|
Health Status Disparities | 3 | 2020 | 1794 | 0.180 |
Why?
|
Dancing | 1 | 2021 | 101 | 0.180 |
Why?
|
Age Distribution | 4 | 2019 | 2900 | 0.180 |
Why?
|
Hepatitis B virus | 2 | 2020 | 513 | 0.180 |
Why?
|
Catastrophic Illness | 1 | 2020 | 57 | 0.180 |
Why?
|
Databases, Factual | 6 | 2015 | 7716 | 0.180 |
Why?
|
El Salvador | 1 | 2019 | 39 | 0.180 |
Why?
|
Medical Assistance | 2 | 2017 | 104 | 0.180 |
Why?
|
Philippines | 1 | 2019 | 86 | 0.180 |
Why?
|
Algorithms | 2 | 2019 | 13853 | 0.180 |
Why?
|
Palliative Care | 4 | 2019 | 3478 | 0.180 |
Why?
|
Health Planning Organizations | 1 | 2019 | 12 | 0.170 |
Why?
|
Patient Satisfaction | 4 | 2019 | 3391 | 0.170 |
Why?
|
Breast Neoplasms | 5 | 2022 | 20774 | 0.170 |
Why?
|
Seasons | 1 | 2005 | 1492 | 0.170 |
Why?
|
Organizational Culture | 2 | 2019 | 510 | 0.170 |
Why?
|
Guatemala | 1 | 2019 | 142 | 0.170 |
Why?
|
Educational Status | 3 | 2020 | 2533 | 0.170 |
Why?
|
Urban Health Services | 1 | 2020 | 179 | 0.170 |
Why?
|
Population Groups | 2 | 2021 | 208 | 0.170 |
Why?
|
Coercion | 1 | 2019 | 63 | 0.170 |
Why?
|
Social Participation | 1 | 2021 | 172 | 0.170 |
Why?
|
Central America | 1 | 2018 | 68 | 0.170 |
Why?
|
Economics | 1 | 2019 | 146 | 0.170 |
Why?
|
Health Services Administration | 2 | 2012 | 64 | 0.170 |
Why?
|
Costs and Cost Analysis | 3 | 2020 | 1679 | 0.170 |
Why?
|
Democratic People's Republic of Korea | 1 | 2018 | 12 | 0.170 |
Why?
|
Republic of Korea | 1 | 2020 | 538 | 0.170 |
Why?
|
Medical Staff, Hospital | 1 | 2003 | 603 | 0.160 |
Why?
|
Financial Management, Hospital | 1 | 2019 | 74 | 0.160 |
Why?
|
Attitude to Health | 1 | 2008 | 2051 | 0.160 |
Why?
|
Environmental Microbiology | 1 | 2018 | 46 | 0.160 |
Why?
|
South America | 1 | 2018 | 181 | 0.160 |
Why?
|
South Africa | 3 | 2019 | 1728 | 0.160 |
Why?
|
Education, Distance | 1 | 2022 | 251 | 0.160 |
Why?
|
Breast Feeding | 2 | 2020 | 1339 | 0.160 |
Why?
|
Nuclear Medicine | 1 | 2021 | 233 | 0.160 |
Why?
|
Anxiety | 1 | 2012 | 4279 | 0.150 |
Why?
|
Africa, Northern | 1 | 2017 | 82 | 0.150 |
Why?
|
Jamaica | 1 | 2017 | 51 | 0.150 |
Why?
|
Health Occupations | 1 | 2019 | 223 | 0.150 |
Why?
|
Influenza, Human | 2 | 2021 | 1472 | 0.150 |
Why?
|
Moldova | 1 | 2016 | 15 | 0.150 |
Why?
|
Marburg Virus Disease | 1 | 2016 | 11 | 0.150 |
Why?
|
Bacteria | 2 | 2018 | 2102 | 0.150 |
Why?
|
Information Systems | 3 | 2010 | 410 | 0.150 |
Why?
|
Public-Private Sector Partnerships | 3 | 2016 | 120 | 0.150 |
Why?
|
Databases as Topic | 1 | 2019 | 475 | 0.150 |
Why?
|
Emigration and Immigration | 1 | 2020 | 403 | 0.150 |
Why?
|
Middle East | 1 | 2017 | 219 | 0.150 |
Why?
|
Siberia | 2 | 2007 | 32 | 0.150 |
Why?
|
Secondary Prevention | 1 | 2023 | 1520 | 0.140 |
Why?
|
Indonesia | 3 | 2021 | 119 | 0.140 |
Why?
|
Africa, Western | 1 | 2016 | 154 | 0.140 |
Why?
|
Cote d'Ivoire | 1 | 2016 | 56 | 0.140 |
Why?
|
Mental Health | 3 | 2020 | 2997 | 0.140 |
Why?
|
Personnel Turnover | 1 | 2016 | 83 | 0.140 |
Why?
|
Rural Health Services | 1 | 2020 | 379 | 0.140 |
Why?
|
Drug and Narcotic Control | 1 | 2017 | 146 | 0.140 |
Why?
|
Stereotyping | 2 | 2010 | 241 | 0.140 |
Why?
|
Zimbabwe | 1 | 2016 | 129 | 0.140 |
Why?
|
Respiratory Tract Diseases | 2 | 2016 | 722 | 0.140 |
Why?
|
Bayes Theorem | 3 | 2021 | 2303 | 0.140 |
Why?
|
Hepatitis B, Chronic | 1 | 2020 | 393 | 0.140 |
Why?
|
Inflation, Economic | 1 | 2016 | 28 | 0.140 |
Why?
|
Body Mass Index | 4 | 2021 | 12695 | 0.140 |
Why?
|
Women's Health | 2 | 2016 | 2034 | 0.140 |
Why?
|
Qualitative Research | 4 | 2019 | 2680 | 0.130 |
Why?
|
Temperature | 1 | 2022 | 2207 | 0.130 |
Why?
|
Job Satisfaction | 1 | 2019 | 535 | 0.130 |
Why?
|
Learning | 4 | 2019 | 1705 | 0.130 |
Why?
|
Peripartum Period | 2 | 2020 | 133 | 0.130 |
Why?
|
Employment | 3 | 2011 | 1124 | 0.130 |
Why?
|
Gross Domestic Product | 1 | 2016 | 76 | 0.130 |
Why?
|
Colorectal Neoplasms | 1 | 2015 | 6754 | 0.130 |
Why?
|
Escherichia coli Infections | 1 | 2019 | 532 | 0.130 |
Why?
|
Interviews as Topic | 4 | 2019 | 2536 | 0.130 |
Why?
|
General Practice | 1 | 2016 | 100 | 0.130 |
Why?
|
West Indies | 1 | 2014 | 34 | 0.130 |
Why?
|
North America | 1 | 2018 | 1249 | 0.130 |
Why?
|
Medication Reconciliation | 1 | 2016 | 151 | 0.130 |
Why?
|
Age Factors | 4 | 2021 | 18355 | 0.130 |
Why?
|
Immunization Programs | 1 | 2017 | 259 | 0.120 |
Why?
|
Longitudinal Studies | 6 | 2022 | 13921 | 0.120 |
Why?
|
Mycology | 1 | 2014 | 13 | 0.120 |
Why?
|
Canada | 1 | 2019 | 2061 | 0.120 |
Why?
|
Inappropriate Prescribing | 1 | 2016 | 202 | 0.120 |
Why?
|
Uganda | 1 | 2019 | 1239 | 0.120 |
Why?
|
Early Diagnosis | 1 | 2019 | 1184 | 0.120 |
Why?
|
Asthma | 1 | 2012 | 5955 | 0.120 |
Why?
|
Clinical Governance | 1 | 2013 | 7 | 0.120 |
Why?
|
Social Isolation | 1 | 2017 | 363 | 0.120 |
Why?
|
Nutrition Surveys | 1 | 2020 | 1656 | 0.120 |
Why?
|
Body Height | 1 | 2020 | 1574 | 0.120 |
Why?
|
Motivation | 2 | 2016 | 1968 | 0.120 |
Why?
|
Prisoners | 3 | 2012 | 296 | 0.120 |
Why?
|
United States | 8 | 2023 | 69693 | 0.120 |
Why?
|
Fruit | 1 | 2019 | 1139 | 0.120 |
Why?
|
Vegetables | 1 | 2019 | 1179 | 0.110 |
Why?
|
Africa | 2 | 2013 | 670 | 0.110 |
Why?
|
Autoantibodies | 1 | 2022 | 2036 | 0.110 |
Why?
|
Family Relations | 1 | 2015 | 321 | 0.110 |
Why?
|
Nevirapine | 2 | 2011 | 267 | 0.110 |
Why?
|
Physicians, Primary Care | 1 | 2019 | 577 | 0.110 |
Why?
|
Electronic Prescribing | 1 | 2014 | 121 | 0.110 |
Why?
|
Governing Board | 1 | 2013 | 53 | 0.110 |
Why?
|
Culture | 2 | 2015 | 632 | 0.110 |
Why?
|
Drug Prescriptions | 3 | 2016 | 1636 | 0.110 |
Why?
|
Research Personnel | 1 | 2018 | 573 | 0.110 |
Why?
|
Infant Nutritional Physiological Phenomena | 1 | 2016 | 347 | 0.110 |
Why?
|
Minority Groups | 1 | 2020 | 1215 | 0.110 |
Why?
|
Family Characteristics | 1 | 2018 | 999 | 0.110 |
Why?
|
Government Agencies | 1 | 2013 | 156 | 0.110 |
Why?
|
Gastroenterology | 1 | 2019 | 534 | 0.110 |
Why?
|
Thinking | 2 | 2012 | 319 | 0.110 |
Why?
|
HIV-1 | 1 | 2010 | 6934 | 0.110 |
Why?
|
London | 3 | 2017 | 233 | 0.110 |
Why?
|
Focus Groups | 3 | 2006 | 1320 | 0.110 |
Why?
|
Risk-Taking | 2 | 2011 | 986 | 0.110 |
Why?
|
Multimedia | 1 | 2012 | 77 | 0.110 |
Why?
|
Statistics as Topic | 1 | 2019 | 2372 | 0.110 |
Why?
|
Bacteremia | 1 | 2019 | 962 | 0.110 |
Why?
|
Cultural Characteristics | 2 | 2012 | 262 | 0.110 |
Why?
|
Maternal Nutritional Physiological Phenomena | 1 | 2016 | 378 | 0.110 |
Why?
|
Observer Variation | 3 | 2019 | 2593 | 0.110 |
Why?
|
Radiotherapy | 2 | 2019 | 1525 | 0.110 |
Why?
|
Quality Improvement | 3 | 2017 | 3738 | 0.110 |
Why?
|
Aged, 80 and over | 9 | 2021 | 57683 | 0.110 |
Why?
|
Lymphatic Metastasis | 1 | 2020 | 2906 | 0.100 |
Why?
|
Outpatients | 2 | 2016 | 1483 | 0.100 |
Why?
|
Community Health Services | 1 | 2017 | 650 | 0.100 |
Why?
|
Human Rights | 1 | 2014 | 302 | 0.100 |
Why?
|
Drug Therapy, Combination | 3 | 2011 | 6483 | 0.100 |
Why?
|
Retrospective Studies | 8 | 2020 | 77098 | 0.100 |
Why?
|
Models, Biological | 2 | 2009 | 9581 | 0.100 |
Why?
|
Aspirin | 1 | 2023 | 3278 | 0.100 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2012 | 224 | 0.100 |
Why?
|
Turkmenistan | 1 | 2010 | 3 | 0.100 |
Why?
|
Diet | 2 | 2020 | 7923 | 0.100 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2009 | 5171 | 0.100 |
Why?
|
Georgia | 2 | 2022 | 185 | 0.100 |
Why?
|
Choice Behavior | 1 | 2016 | 802 | 0.090 |
Why?
|
Organizational Policy | 1 | 2013 | 427 | 0.090 |
Why?
|
Perinatal Mortality | 1 | 2011 | 105 | 0.090 |
Why?
|
Hyperglycemia | 1 | 2019 | 1368 | 0.090 |
Why?
|
Mycoses | 1 | 2014 | 376 | 0.090 |
Why?
|
Home Care Services | 1 | 2017 | 602 | 0.090 |
Why?
|
HIV Seronegativity | 1 | 2011 | 211 | 0.090 |
Why?
|
Causality | 1 | 2017 | 1265 | 0.090 |
Why?
|
Ukraine | 2 | 2008 | 111 | 0.090 |
Why?
|
Social Environment | 1 | 2015 | 1023 | 0.090 |
Why?
|
Zambia | 1 | 2011 | 261 | 0.090 |
Why?
|
Congresses as Topic | 2 | 2018 | 764 | 0.090 |
Why?
|
Technology | 1 | 2012 | 303 | 0.090 |
Why?
|
Awards and Prizes | 1 | 2014 | 375 | 0.090 |
Why?
|
Diagnostic Tests, Routine | 2 | 2012 | 783 | 0.090 |
Why?
|
Communicable Diseases, Emerging | 1 | 2011 | 156 | 0.090 |
Why?
|
Labor, Obstetric | 1 | 2013 | 333 | 0.090 |
Why?
|
Refugees | 1 | 2016 | 510 | 0.090 |
Why?
|
Mass Media | 1 | 2012 | 303 | 0.090 |
Why?
|
Cardiovascular Agents | 2 | 2023 | 848 | 0.090 |
Why?
|
Abortion, Induced | 1 | 2015 | 458 | 0.080 |
Why?
|
Blood Glucose | 2 | 2023 | 6249 | 0.080 |
Why?
|
Drug Users | 1 | 2010 | 131 | 0.080 |
Why?
|
Unsafe Sex | 1 | 2010 | 220 | 0.080 |
Why?
|
Combined Modality Therapy | 1 | 2021 | 8621 | 0.080 |
Why?
|
Checklist | 1 | 2016 | 830 | 0.080 |
Why?
|
Confidentiality | 1 | 2013 | 609 | 0.080 |
Why?
|
Quality Assurance, Health Care | 1 | 2019 | 2211 | 0.080 |
Why?
|
Vaccination | 4 | 2022 | 3256 | 0.080 |
Why?
|
Autopsy | 1 | 2012 | 1006 | 0.080 |
Why?
|
Social Marketing | 1 | 2008 | 51 | 0.080 |
Why?
|
Latent Tuberculosis | 1 | 2011 | 225 | 0.080 |
Why?
|
Cerebrovascular Disorders | 1 | 2015 | 1499 | 0.080 |
Why?
|
Social Change | 2 | 2021 | 153 | 0.080 |
Why?
|
Esophagoscopy | 1 | 2009 | 390 | 0.080 |
Why?
|
Immunization | 1 | 2012 | 1255 | 0.070 |
Why?
|
Papillomavirus Infections | 1 | 2019 | 1585 | 0.070 |
Why?
|
Nutritional Status | 1 | 2015 | 1606 | 0.070 |
Why?
|
Sexual Partners | 1 | 2011 | 730 | 0.070 |
Why?
|
Ultrasonography | 1 | 2020 | 5978 | 0.070 |
Why?
|
Drug Administration Schedule | 2 | 2012 | 4929 | 0.070 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2022 | 3239 | 0.070 |
Why?
|
Treatment Outcome | 9 | 2021 | 62966 | 0.070 |
Why?
|
Drug Evaluation | 1 | 2008 | 637 | 0.070 |
Why?
|
Self Report | 3 | 2023 | 3548 | 0.070 |
Why?
|
Organizations | 2 | 2021 | 170 | 0.070 |
Why?
|
Physicians | 3 | 2017 | 4554 | 0.070 |
Why?
|
Mammography | 1 | 2017 | 2474 | 0.070 |
Why?
|
Political Systems | 1 | 2005 | 23 | 0.070 |
Why?
|
Pregnant Women | 1 | 2011 | 566 | 0.070 |
Why?
|
Malawi | 3 | 2011 | 281 | 0.070 |
Why?
|
Social Support | 1 | 2015 | 2117 | 0.070 |
Why?
|
Housing | 1 | 2010 | 663 | 0.070 |
Why?
|
Australia | 1 | 2009 | 1167 | 0.070 |
Why?
|
Emergency Medical Services | 1 | 2017 | 1914 | 0.070 |
Why?
|
Ethiopia | 2 | 2021 | 494 | 0.070 |
Why?
|
Medication Adherence | 1 | 2017 | 2055 | 0.060 |
Why?
|
Lung Neoplasms | 1 | 2009 | 13019 | 0.060 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2009 | 780 | 0.060 |
Why?
|
Hepatitis B Vaccines | 2 | 2020 | 194 | 0.060 |
Why?
|
Caregivers | 1 | 2017 | 2074 | 0.060 |
Why?
|
Multivariate Analysis | 3 | 2015 | 12242 | 0.060 |
Why?
|
Inpatients | 1 | 2016 | 2495 | 0.060 |
Why?
|
Abnormalities, Drug-Induced | 1 | 2008 | 316 | 0.060 |
Why?
|
Medical Audit | 1 | 2006 | 467 | 0.060 |
Why?
|
Drug Resistance | 1 | 2010 | 1608 | 0.060 |
Why?
|
Pharmaceutical Preparations | 1 | 2013 | 1071 | 0.060 |
Why?
|
Isoniazid | 3 | 2012 | 273 | 0.060 |
Why?
|
Sexually Transmitted Diseases | 1 | 2010 | 622 | 0.060 |
Why?
|
Malnutrition | 1 | 2010 | 625 | 0.060 |
Why?
|
Population Dynamics | 1 | 2005 | 301 | 0.060 |
Why?
|
Benchmarking | 1 | 2010 | 1038 | 0.060 |
Why?
|
Prognosis | 2 | 2021 | 29010 | 0.060 |
Why?
|
Nutritional Physiological Phenomena | 1 | 2005 | 370 | 0.060 |
Why?
|
Trust | 1 | 2008 | 501 | 0.060 |
Why?
|
Epidemiology | 1 | 2006 | 287 | 0.060 |
Why?
|
Pulmonary Medicine | 1 | 2005 | 213 | 0.060 |
Why?
|
Demography | 2 | 2020 | 1650 | 0.060 |
Why?
|
Health Services Misuse | 1 | 2005 | 243 | 0.060 |
Why?
|
Dementia | 1 | 2017 | 2501 | 0.050 |
Why?
|
Pregnancy Outcome | 1 | 2013 | 2795 | 0.050 |
Why?
|
Risk | 2 | 2021 | 9679 | 0.050 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2008 | 1372 | 0.050 |
Why?
|
Counseling | 1 | 2010 | 1521 | 0.050 |
Why?
|
Prejudice | 1 | 2006 | 569 | 0.050 |
Why?
|
Obesity | 2 | 2021 | 12705 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3130 | 0.050 |
Why?
|
Decision Making | 2 | 2019 | 3869 | 0.050 |
Why?
|
Education, Medical, Continuing | 1 | 2007 | 839 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3236 | 0.050 |
Why?
|
Federal Government | 1 | 2003 | 260 | 0.050 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2016 | 3915 | 0.050 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2005 | 253 | 0.050 |
Why?
|
Brain Neoplasms | 1 | 2023 | 8829 | 0.050 |
Why?
|
Antirheumatic Agents | 1 | 2011 | 1335 | 0.050 |
Why?
|
Practice Guidelines as Topic | 3 | 2016 | 7276 | 0.050 |
Why?
|
Thailand | 1 | 2022 | 296 | 0.050 |
Why?
|
Cross-Cultural Comparison | 2 | 2015 | 651 | 0.050 |
Why?
|
Mycobacterium tuberculosis | 1 | 2012 | 1825 | 0.050 |
Why?
|
Public Health Administration | 1 | 2003 | 239 | 0.050 |
Why?
|
Feasibility Studies | 1 | 2011 | 5062 | 0.050 |
Why?
|
Bacteriological Techniques | 2 | 2012 | 276 | 0.050 |
Why?
|
Ethics, Medical | 1 | 2006 | 791 | 0.050 |
Why?
|
Public Opinion | 2 | 2019 | 477 | 0.050 |
Why?
|
Saint Vincent and the Grenadines | 1 | 2020 | 3 | 0.050 |
Why?
|
Guyana | 1 | 2020 | 13 | 0.050 |
Why?
|
Bhutan | 1 | 2020 | 59 | 0.050 |
Why?
|
Mass Screening | 3 | 2011 | 5238 | 0.050 |
Why?
|
Social Security | 1 | 2020 | 100 | 0.040 |
Why?
|
Women, Working | 1 | 2020 | 87 | 0.040 |
Why?
|
Communication | 2 | 2016 | 3728 | 0.040 |
Why?
|
Decision Support Systems, Clinical | 1 | 2009 | 1162 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2021 | 39004 | 0.040 |
Why?
|
Kazakhstan | 1 | 2018 | 14 | 0.040 |
Why?
|
Papillomavirus Vaccines | 2 | 2019 | 489 | 0.040 |
Why?
|
Multilevel Analysis | 1 | 2019 | 142 | 0.040 |
Why?
|
Radiography, Thoracic | 1 | 2005 | 1265 | 0.040 |
Why?
|
Nepal | 1 | 2020 | 294 | 0.040 |
Why?
|
Nigeria | 1 | 2021 | 731 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2017 | 19862 | 0.040 |
Why?
|
Holistic Health | 1 | 2018 | 47 | 0.040 |
Why?
|
Foodborne Diseases | 1 | 2018 | 39 | 0.040 |
Why?
|
Teaching | 1 | 2006 | 1174 | 0.040 |
Why?
|
Sweden | 1 | 2021 | 1343 | 0.040 |
Why?
|
Uncertainty | 1 | 2023 | 725 | 0.040 |
Why?
|
Climate Change | 1 | 2023 | 410 | 0.040 |
Why?
|
Population Density | 1 | 2018 | 194 | 0.040 |
Why?
|
Kenya | 1 | 2020 | 685 | 0.040 |
Why?
|
Social Responsibility | 1 | 2020 | 389 | 0.040 |
Why?
|
Tanzania | 1 | 2021 | 1344 | 0.040 |
Why?
|
Education, Medical, Undergraduate | 1 | 2006 | 1004 | 0.040 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2008 | 1421 | 0.040 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2021 | 457 | 0.040 |
Why?
|
Depression | 1 | 2016 | 7733 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 1 | 2020 | 20086 | 0.040 |
Why?
|
Case-Control Studies | 2 | 2012 | 21719 | 0.040 |
Why?
|
Tsunamis | 1 | 2017 | 59 | 0.040 |
Why?
|
Syria | 1 | 2016 | 75 | 0.040 |
Why?
|
Information Storage and Retrieval | 1 | 2022 | 824 | 0.040 |
Why?
|
Patient Education as Topic | 2 | 2016 | 2275 | 0.040 |
Why?
|
Nurses | 1 | 2006 | 2459 | 0.030 |
Why?
|
Lebanon | 1 | 2016 | 227 | 0.030 |
Why?
|
Principal Component Analysis | 1 | 2019 | 939 | 0.030 |
Why?
|
Length of Stay | 2 | 2006 | 6294 | 0.030 |
Why?
|
Vulnerable Populations | 1 | 2021 | 685 | 0.030 |
Why?
|
Social Stigma | 1 | 2021 | 698 | 0.030 |
Why?
|
Risk Assessment | 4 | 2021 | 23320 | 0.030 |
Why?
|
Disaster Planning | 1 | 2021 | 549 | 0.030 |
Why?
|
Earthquakes | 1 | 2017 | 179 | 0.030 |
Why?
|
Public Health Practice | 1 | 2016 | 217 | 0.030 |
Why?
|
Guidelines as Topic | 1 | 2021 | 1402 | 0.030 |
Why?
|
Polypharmacy | 1 | 2016 | 294 | 0.030 |
Why?
|
Sex Distribution | 1 | 2019 | 2295 | 0.030 |
Why?
|
Problem Solving | 1 | 2016 | 440 | 0.030 |
Why?
|
Pregnancy Complications | 1 | 2008 | 2861 | 0.030 |
Why?
|
Communication Barriers | 1 | 2016 | 398 | 0.030 |
Why?
|
Fasting | 1 | 2019 | 1589 | 0.030 |
Why?
|
Incubators, Infant | 1 | 2012 | 6 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2020 | 35342 | 0.030 |
Why?
|
Japan | 1 | 2017 | 1360 | 0.030 |
Why?
|
Cost Control | 1 | 2015 | 624 | 0.030 |
Why?
|
Tropical Medicine | 1 | 2012 | 49 | 0.030 |
Why?
|
Insecticide-Treated Bednets | 1 | 2012 | 64 | 0.030 |
Why?
|
Weight Loss | 1 | 2023 | 2604 | 0.030 |
Why?
|
Consensus | 1 | 2021 | 2935 | 0.030 |
Why?
|
Cholesterol | 1 | 2021 | 2895 | 0.030 |
Why?
|
History, 19th Century | 1 | 2014 | 720 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2020 | 3612 | 0.030 |
Why?
|
Sanitation | 1 | 2012 | 93 | 0.030 |
Why?
|
Ambulances | 1 | 2012 | 95 | 0.030 |
Why?
|
Patient Transfer | 1 | 2019 | 760 | 0.030 |
Why?
|
Hepacivirus | 1 | 2019 | 1372 | 0.020 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2020 | 2013 | 0.020 |
Why?
|
Stress, Psychological | 1 | 2006 | 4229 | 0.020 |
Why?
|
Animals | 3 | 2016 | 168561 | 0.020 |
Why?
|
Disasters | 1 | 2017 | 510 | 0.020 |
Why?
|
Mass Vaccination | 1 | 2012 | 105 | 0.020 |
Why?
|
Water Supply | 1 | 2012 | 214 | 0.020 |
Why?
|
Education, Medical | 1 | 2003 | 1717 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2021 | 6891 | 0.020 |
Why?
|
Hunger | 1 | 2012 | 198 | 0.020 |
Why?
|
Rural Health | 1 | 2012 | 305 | 0.020 |
Why?
|
Microbial Sensitivity Tests | 1 | 2016 | 1871 | 0.020 |
Why?
|
Jordan | 1 | 2010 | 74 | 0.020 |
Why?
|
Workplace | 1 | 2016 | 836 | 0.020 |
Why?
|
Point-of-Care Systems | 1 | 2019 | 1175 | 0.020 |
Why?
|
Pakistan | 1 | 2011 | 296 | 0.020 |
Why?
|
Epidemiologic Methods | 1 | 2015 | 1364 | 0.020 |
Why?
|
Lamivudine | 1 | 2011 | 342 | 0.020 |
Why?
|
Esophagoscopes | 1 | 2009 | 18 | 0.020 |
Why?
|
Abortion, Spontaneous | 1 | 2015 | 542 | 0.020 |
Why?
|
Colombia | 1 | 2010 | 259 | 0.020 |
Why?
|
Radiography | 1 | 2021 | 7010 | 0.020 |
Why?
|
Clinical Competence | 1 | 2005 | 4681 | 0.020 |
Why?
|
Alcohol Drinking | 1 | 2022 | 3957 | 0.020 |
Why?
|
Smoking Cessation | 2 | 2012 | 2068 | 0.020 |
Why?
|
Zidovudine | 1 | 2011 | 620 | 0.020 |
Why?
|
Inservice Training | 1 | 2012 | 392 | 0.020 |
Why?
|
Glucose | 1 | 2021 | 4391 | 0.020 |
Why?
|
Radiation Oncology | 1 | 2015 | 554 | 0.020 |
Why?
|
Foot | 1 | 2012 | 528 | 0.020 |
Why?
|
Malaria, Vivax | 1 | 2010 | 172 | 0.020 |
Why?
|
Linear Models | 1 | 2019 | 5948 | 0.020 |
Why?
|
Haiti | 1 | 2010 | 551 | 0.020 |
Why?
|
Advisory Committees | 1 | 2012 | 773 | 0.020 |
Why?
|
HIV Long-Term Survivors | 1 | 2008 | 126 | 0.020 |
Why?
|
Rwanda | 1 | 2010 | 704 | 0.020 |
Why?
|
Genomics | 1 | 2023 | 5692 | 0.020 |
Why?
|
Periodicals as Topic | 1 | 2018 | 1431 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2010 | 13655 | 0.020 |
Why?
|
Lung Diseases | 1 | 2017 | 1884 | 0.020 |
Why?
|
Cohort Studies | 2 | 2006 | 40450 | 0.020 |
Why?
|
Accidents, Traffic | 1 | 2012 | 819 | 0.020 |
Why?
|
Viral Vaccines | 1 | 2012 | 636 | 0.020 |
Why?
|
Equipment and Supplies | 1 | 2009 | 281 | 0.020 |
Why?
|
Bed Occupancy | 1 | 2006 | 41 | 0.020 |
Why?
|
Registries | 1 | 2022 | 8077 | 0.020 |
Why?
|
Exercise | 1 | 2023 | 5611 | 0.020 |
Why?
|
Informed Consent | 1 | 2012 | 991 | 0.020 |
Why?
|
Logistic Models | 1 | 2020 | 13403 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15056 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2020 | 14720 | 0.020 |
Why?
|
Prostheses and Implants | 1 | 2012 | 1385 | 0.020 |
Why?
|
Republic of Belarus | 1 | 2004 | 38 | 0.020 |
Why?
|
Disease Notification | 1 | 2005 | 97 | 0.020 |
Why?
|
Smoking | 1 | 2021 | 8969 | 0.020 |
Why?
|
Anemia, Sickle Cell | 1 | 2012 | 1017 | 0.010 |
Why?
|
Rifampin | 1 | 2006 | 315 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2020 | 6259 | 0.010 |
Why?
|
Terminology as Topic | 1 | 2011 | 1548 | 0.010 |
Why?
|
Physician-Patient Relations | 1 | 2016 | 3215 | 0.010 |
Why?
|
Milk | 1 | 2005 | 449 | 0.010 |
Why?
|
Host-Pathogen Interactions | 1 | 2011 | 1477 | 0.010 |
Why?
|
Body Weight | 1 | 2012 | 4664 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2017 | 7901 | 0.010 |
Why?
|
Residence Characteristics | 1 | 2010 | 2049 | 0.010 |
Why?
|
Treatment Failure | 1 | 2006 | 2615 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2005 | 2885 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2019 | 7645 | 0.010 |
Why?
|
Drug Utilization | 1 | 2004 | 1181 | 0.010 |
Why?
|
Patient Care Team | 1 | 2009 | 2527 | 0.010 |
Why?
|
ROC Curve | 1 | 2005 | 3528 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2017 | 11690 | 0.010 |
Why?
|
Stroke | 1 | 2017 | 9963 | 0.010 |
Why?
|
Recurrence | 1 | 2006 | 8333 | 0.010 |
Why?
|
Odds Ratio | 1 | 2005 | 9846 | 0.010 |
Why?
|
Curriculum | 1 | 2006 | 3589 | 0.010 |
Why?
|
Prospective Studies | 1 | 2006 | 53187 | 0.000 |
Why?
|